共 50 条
- [2] Dose selection of siltuximab for multicentric Castleman’s disease [J]. Cancer Chemotherapy and Pharmacology, 2015, 75 : 1037 - 1045
- [8] Impact of siltuximab on patient-related outcomes in multicentric Castleman's disease [J]. PATIENT-RELATED OUTCOME MEASURES, 2018, 9 : 35 - 41
- [9] The clinical, laboratory, and radiologic improvement due to siltuximab treatment in idiopathic multicentric Castleman's disease [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (02): : 424 - 432